Caris Life Sciences (CAI) Co-Chair and Executive Vice President Brian Brille discusses their IPO and using AI in medical care. Caris is a precision oncology company that offers personalized treatment using genomic sequencing and data. “We’re a pioneer in genomics…more information equals more power.” He explains the company’s process and why AI is a useful tool in the field. He also talks about their unusual partnership structures with other companies.